Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Home
  2. /VCs
  3. /Willem Broekaert
  4. /Briefing
Pre-Pitch Briefing

Willem Broekaert

Managing Partner at V-Bio Ventures

Check size: V-Bio does not publish a standard current startup check-size range on its official site.

Company CreationEarly StageMid StageBiotechnologyTherapeuticsDrug DiscoveryLife SciencesHealthcare

Their Thesis

The official roster identifies Willem Broekaert as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Turn differentiated European science into therapeutics companies with strong impact potential, using a preferred relationship with VIB and wider academic sourcing.

How to Pitch Them

Lead with founder-market fit, the specific problem, differentiated product or technology, evidence of demand, market size, round stage and why the opportunity matches V-Bio Ventures's published focus. Address the role of Managing Partner without assuming individual check authority.

What Excites Them

At firm level, V-Bio Ventures is aligned with turn differentiated European science into therapeutics companies with strong impact potential, using a preferred relationship with VIB and wider academic sourcing. This is firm-level guidance, not an invented personal preference.

What They Pass On

No personal pass list is public. Opportunities outside V-Bio Ventures's stated stages, sectors, geography or team criteria should be treated as lower fit rather than a confirmed personal rejection rule.

← Full profileV-Bio Ventures website